FR2895262B1 - Inhibition de la reponse immunitaire anti-fviii - Google Patents

Inhibition de la reponse immunitaire anti-fviii

Info

Publication number
FR2895262B1
FR2895262B1 FR0513120A FR0513120A FR2895262B1 FR 2895262 B1 FR2895262 B1 FR 2895262B1 FR 0513120 A FR0513120 A FR 0513120A FR 0513120 A FR0513120 A FR 0513120A FR 2895262 B1 FR2895262 B1 FR 2895262B1
Authority
FR
France
Prior art keywords
inhibition
immune response
fviii immune
fviii
response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0513120A
Other languages
English (en)
Other versions
FR2895262A1 (fr
Inventor
Srinivas Kaveri
Desmzes Sebastien Lacroix
Jagadeesh Bayry
Suryasarathi Dasgupta
Abdessatar Sami Chtourou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
LFB SA
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
LFB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0513120A priority Critical patent/FR2895262B1/fr
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, LFB SA filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to JP2008546528A priority patent/JP4906873B2/ja
Priority to CNA2006800486723A priority patent/CN101356193A/zh
Priority to BRPI0621020-1A priority patent/BRPI0621020A2/pt
Priority to AU2006328809A priority patent/AU2006328809B2/en
Priority to EP06847152A priority patent/EP1976875A2/fr
Priority to PCT/FR2006/002892 priority patent/WO2007071850A2/fr
Priority to CA002634608A priority patent/CA2634608A1/fr
Priority to US12/086,851 priority patent/US20090317373A1/en
Priority to KR1020087017294A priority patent/KR20090003152A/ko
Publication of FR2895262A1 publication Critical patent/FR2895262A1/fr
Priority to IL192171A priority patent/IL192171A0/en
Application granted granted Critical
Publication of FR2895262B1 publication Critical patent/FR2895262B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR0513120A 2005-12-22 2005-12-22 Inhibition de la reponse immunitaire anti-fviii Expired - Fee Related FR2895262B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR0513120A FR2895262B1 (fr) 2005-12-22 2005-12-22 Inhibition de la reponse immunitaire anti-fviii
US12/086,851 US20090317373A1 (en) 2005-12-22 2006-12-22 Inhibition of the Anti-FVIII Immune Response
BRPI0621020-1A BRPI0621020A2 (pt) 2005-12-22 2006-12-22 inibição da resposta imune anti-fviii
AU2006328809A AU2006328809B2 (en) 2005-12-22 2006-12-22 Inhibition of the anti-FVIII immune response
EP06847152A EP1976875A2 (fr) 2005-12-22 2006-12-22 Inhibition de la réponse immunitaire anti-fviii
PCT/FR2006/002892 WO2007071850A2 (fr) 2005-12-22 2006-12-22 Inhibition de la réponse immunitaire anti-fviii
JP2008546528A JP4906873B2 (ja) 2005-12-22 2006-12-22 抗ｆｖｉｉｉ免疫応答を阻害する方法
CNA2006800486723A CN101356193A (zh) 2005-12-22 2006-12-22 抗fviii免疫反应的抑制
KR1020087017294A KR20090003152A (ko) 2005-12-22 2006-12-22 항―ｆｖｉｉｉ 면역 반응의 억제
CA002634608A CA2634608A1 (fr) 2005-12-22 2006-12-22 Inhibition of the anti-fviii immune response
IL192171A IL192171A0 (en) 2005-12-22 2008-06-15 Inhibition of the anti-fviii immune response

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0513120A FR2895262B1 (fr) 2005-12-22 2005-12-22 Inhibition de la reponse immunitaire anti-fviii

Publications (2)

Publication Number Publication Date
FR2895262A1 FR2895262A1 (fr) 2007-06-29
FR2895262B1 true FR2895262B1 (fr) 2009-07-17

Family

ID=37308887

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0513120A Expired - Fee Related FR2895262B1 (fr) 2005-12-22 2005-12-22 Inhibition de la reponse immunitaire anti-fviii

Country Status (11)

Country Link
US (1) US20090317373A1 (fr)
EP (1) EP1976875A2 (fr)
JP (1) JP4906873B2 (fr)
KR (1) KR20090003152A (fr)
CN (1) CN101356193A (fr)
AU (1) AU2006328809B2 (fr)
BR (1) BRPI0621020A2 (fr)
CA (1) CA2634608A1 (fr)
FR (1) FR2895262B1 (fr)
IL (1) IL192171A0 (fr)
WO (1) WO2007071850A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2933496B1 (fr) * 2008-07-02 2012-10-05 Lfb Biotechnologies Procede de mesure du taux de facteur vii active dans un echantillon

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614795A (en) * 1982-08-05 1986-09-30 University Of Rochester Deglycosylated Human Factor VIII:C
EP1046651A1 (fr) * 1999-04-19 2000-10-25 Koninklijke Universiteit Nijmegen Composition et méthode pour moduler l'interaction des cellules dendritiques et les cellules T
WO2004070009A2 (fr) * 2003-01-31 2004-08-19 Targesome Inc. Macromolecules multivalentes ciblees

Also Published As

Publication number Publication date
JP2009520775A (ja) 2009-05-28
IL192171A0 (en) 2009-02-11
CA2634608A1 (fr) 2007-06-28
BRPI0621020A2 (pt) 2012-05-02
JP4906873B2 (ja) 2012-03-28
WO2007071850A2 (fr) 2007-06-28
FR2895262A1 (fr) 2007-06-29
AU2006328809A1 (en) 2007-06-28
KR20090003152A (ko) 2009-01-09
CN101356193A (zh) 2009-01-28
WO2007071850A3 (fr) 2007-09-13
EP1976875A2 (fr) 2008-10-08
US20090317373A1 (en) 2009-12-24
AU2006328809B2 (en) 2011-11-03

Similar Documents

Publication Publication Date Title
CY2022001I1 (el) Παραγωγα του uk-2a
DE602006016150D1 (de) Vorbeugung von krankheiten bei kaiserschnitt-babies
DK2402005T3 (da) Formuleringer med langvarig frigivelse af nalbuphin
DK1720866T3 (da) Fremgangsmåde
ATE521238T1 (de) Kristalline modifikationen des pyraclostrobins
DE602005009127D1 (de) Siliziumverbindung
NO20055643D0 (no) Preparation of lodixanol
AT502275B8 (de) Immunantwort-induzierende zusammensetzungen
ITMI20042437A1 (it) Forma cristallina di rabeprazolo sodico
FR2895262B1 (fr) Inhibition de la reponse immunitaire anti-fviii
ITMI20052367A1 (it) Cristallizzatore
FR2877833B1 (fr) Correcteur de lordoses
NO20055630D0 (no) SmartCoupling - non responsive
ITRM20050612A1 (it) Cristallizzatore
ES1059020Y (es) Vestidor de playa
SE0800352L (sv) Gåhjälp
SE0402803D0 (sv) Lokalisering av objekt på havet
FR2865930B3 (fr) Civiere de commodite
UA11801S (uk) Черепиця фронтонна
UA11802S (uk) Черепиця фронтонна
ITMI20060238A1 (it) Liccio specialmente liccio di levata
UA11866S (uk) Комплект спецодягу
ITPS20050012A1 (it) Struttura di fitodepuratore
ITVI20050244A1 (it) Struttura di colonnina
ITVR20050133A1 (it) Struttura di monile

Legal Events

Date Code Title Description
CL Concession to grant licences
TQ Partial transmission of property
ST Notification of lapse

Effective date: 20140829